Nephron-sparing surgery (NSS) for renal cell carcinoma (RCC) offers comparable oncologic results, but a lower risk of chronic kidney disease, when compared with radical nephrectomy. However, there are limited data in the literature examining the safety of NSS in the setting of metastatic RCC. To evaluate the feasibility of NSS and impact on cancer-specific survival (CSS) in patients with metastatic disease, we performed a systematic review of the literature. There is ample evidence that NSS is feasible in metastatic RCC, with comparable results in terms of CSS compared with radical cytoreductive nephrectomy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397543 | PMC |
| http://dx.doi.org/10.4103/0970-1591.154300 | DOI Listing |
Publication Analysis
Top Keywords
renal cell
8
cell carcinoma
8
compared radical
8
metastatic rcc
8
partial nephrectomy
4
metastatic
4
nephrectomy metastatic
4
metastatic renal
4
carcinoma stand?
4
stand? nephron-sparing
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!